By Kirsten Ballard “Horse tranquilizer,” “Special K,” and other misnomers. For much of its known existence, ketamine...
Blog Articles
NAVIGATING THE CLASSES OF MEDICATIONS USED TO TREAT NEUROPATHIC PAIN: WHAT YOU SHOULD KNOW
By Ashley Hattle People living with neuropathic pain face an uphill battle in their efforts to achieve symptom relief,...
NEUROPATHIC PAIN GLOSSARY
THE FOUR MAIN CAUSES OF NEUROPATHIC PAIN Disease: Many diseases can cause neuropathic pain, but 30% of cases are due...
CDC announces comment period to inform update of opioid guideline
On April 17, the Centers for Disease and Control and Prevention (CDC) opened an official docket requesting comments...
Mindfull
By: Mia Maysack How are we able to go about pursuing or even simply believing in the concept of wellness, while...
Join a May 4 webinar on finding balance during crisis
In our recent survey, when asked "What resources would be most helpful to you right now," a majority of you responded...
Have you written to your legislator yet?
Have you participated in our email-writing campaign asking policymakers to ensure patients with pain have access to...
Pediatric pain warriors: Join us for storytime and interactive PT
U.S. Pain's Pediatric Pain Warriors Program has announced its latest special events and programming for this week:...
Tried and tested products for migraine
By Jaime Sanders Google “migraine products” and more than 48 million search results come up. How do you even begin to...
A decade of making the invisible visible
The evolution of the INvisible Project. In 2010, Nicole Hemmenway was relatively new to patient advocacy. She had just...
Coping with high-frequency episodic migraine
By Kerrie Smyres Chronic and episodic migraine, two classifications of migraine disease, are often treated like two...
Diversity, equity, and inclusion in migraine disease
By Jamie Sanders Throughout my years living with migraine, I have been confronted with many obstacles. The biggest...